Abstract
The following study is investigating the different GyrB mutations associated withEscherichia coliclinical isolates. The study interrogates part of the ATPase binding site (a.a 132-199) as it covers most of the naturally occurring mutations in GyrB. The following results were obtained: for Arg-136 two isolates had mutations, the first is isolate-1 (Ala-136), and the second is isolate-5 (Cys-136). Gly-164 had no changes for all tested isolates. For Thr-165 only isolate-3 had a change to Ser-165. Accuracy of sequence translation was checked by sequencing both CFT073 and MG1655. The current study presents novel mutations in the GyrB24 subdomain of the gyrase enzyme. These new mutations showed normal enzyme activity (no reduction in ATPase functions) indicating that they might be a result of GyrB interaction with ATP analog molecules rather than antibacterial agents such as coumarins. Furthermore, our findings are supporting the idea that mutations in the GyrB24 would require synchronization with the efflux pumps to maintain antibiotic resistance against coumarins.
Publisher
Trans Tech Publications, Ltd.
Reference34 articles.
1. F. Collin, S. Karkare, A. Maxwell, Exploiting bacterial DNA gyrase as a drug target: current state and perspectives, Appl Microbiol Biotechnol 92(3) (2011) 479-97.
2. H.M. Al-Emran, A. Heisig, D. Dekker, Y. Adu-Sarkodie, L.M. Cruz Espinoza, U. Panzner, V. von Kalckreuth, F. Marks, S.E. Park, N. Sarpong, J. May, P. Heisig, Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana, Clin Infect Dis 62 Suppl 1 (2016).
3. A. Alessiani, E. Di Giannatale, M. Perilli, C. Forcella, G. Amicosante, K. Zilli, Preliminary investigations into fluoroquinolone resistance in Escherichia coli strains resistant to nalidixic acid isolated from animal faeces, Vet Ital 45(4) (2009).
4. L. Brino, A. Urzhumtsev, M. Mousli, C. Bronner, A. Mitschler, P. Oudet, D. Moras, Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center, J Biol Chem 275(13) (2000) 9468-75.
5. R.J. Lewis, O.M. Singh, C.V. Smith, T. Skarzynski, A. Maxwell, A.J. Wonacott, D.B. Wigley, The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography, EMBO J 15(6) (1996) 1412-20.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献